max word count = 250 52 3 Background: DICER1 is the only miRNA biogenesis component associated with an inherited 53 tumor syndrome, featuring multinodular goiter (MNG) and rare pediatric-onset lesions. Other 54 susceptibility genes for familial forms of MNG likely exist. 55 Methods: Whole exome sequencing of a kindred with early-onset MNG and schwannomatosis 56 was followed by investigation of germline pathogenic variants that fully segregated with the 57 disease. Genome wide analyses were performed on 13 tissue samples from familial and non-58 familial DGCR8-E518K positive tumors, including MNG, schwannomas, papillary thyroid 59 cancers (PTC) and Wilms Tumors. MiRNA profiles of four tissue types were compared, and 60 sequencing of miRNA, pre-miRNA and mRNA was performed in a subset of 9 schwannomas, 61 four of which harbor DGCR8-E518K.
7 from II-2 III-1, III-2, III-3, as well as the CPT, showed loss of the entire chromosome 22, 157 explaining the presence of LOH. Schwannomas from I-1 and II-2 and the CPT from III-1 showed 158 allelic imbalance in the WES data, suggesting a loss of chromosome 22 (Figure 1, 159 Supplementary Tables 3-6 and Supplementary Figures 5 and 6) . We sequenced the DGCR8 The variant is located in helix 1 of the first of two double-strand RNA-binding domains within 176 DGCR8 and the corresponding mRNA is expressed and detected both by RT-PCR followed by 177 Sanger sequencing and by RNA-seq, suggesting that it is translated ( Supplementary Figure 4 ).
178
The E518 residue is responsible for forming a critical hydrogen bond with the 2' hydroxyl group 179 of the pentose ring in the RNA molecule. In-silico modeling predicts that mutating amino acid 
196
We then focused on family members. miRNA and mRNA profiling of peripheral blood 197 mononuclear cells showed no differences between those family members heterozygous for 198 c.1552G>A and those who did not possess this variant (data not shown). At the somatic level, 
209
MiRNA and mRNA profiling of DGCR8-mutated schwannomas showed differences in their 210 mRNA and miRNA expression patterns compared to DGCR8-wild type schwannomas (Figure
211
4A-B and Supplementary Tables 9 and 10). Similar results were found for the expression 212 pattern of the pre-miRNAs (Supplementary Figure 11 ) and, despite reduced power to identify 213 statistically significant alterations (false discovery rate < 1%), several pre-miRNAs were 214 differentially expressed compared to wild type DGCR8 tumors. As expected, comparison 215 between the two groups confirmed that differentially expressed precursor and mature miRNA 216 levels were altered in the same direction, indicating that deficiency of the precursor miRNA likely 217 results in underproduction of its corresponding mature miRNA ( Figure 4A and Supplementary
218
Figures 11 and 12). To confirm that the deficiency in mature miRNA is due to a defective 219 cleavage of the corresponding pre-miRNA, we performed an in vitro cleavage experiment. For 220 this purpose, we chose miR-30c-2, as it i) showed the most highly significant p-value among the 221 190 common differentially expressed miRNAs in the two tumor sets (Supplementary Figure 10 222 and Supplementary Tables 9 and 11) and ii) was also confirmed to be an underrepresented pre-223 miRNA in the mutated schwannomas ( Supplementary Figure 12) . As a control we chose miR-224 223, a miRNA that was invariant in both datasets. The in vitro data validated that DGCR8-
225
E518K is incapable of trimming primary-miR-30c-2 into the precursor form of miR-30c-2 (Figure
226
4C) while it has no effect in the processing of pri-miR-223 ( Supplementary Figure 13 ). 
233
E518K and 5 DGCR8-wild type), 113 (81%) were overrepresented in DGCR8-mutated 234 235 Supplementary Table 12 ). The same analysis was then applied to the Wilms Tumor datasets 236 with similar results, validating our hypothesis ( Figure 4D ). In parallel, we performed the same 237 analysis using an in-house dataset of pituitary blastomas(22) with mutations in DICER1 (n = 3) 238 compared to normal fetal (n = 3) and adult (n = 4) pituitaries. In this scenario, 13% of expressed 239 mirtrons were overrepresented and 8% were underrepresented in DICER1-mutated tumors 240 ( Supplementary Figure 14 and Supplementary Table 12 ). Taken together, these findings 241 confirmed that the differences in the miRNA profiles of DGCR8-mutated and wild type tumors 242 result from a defective microprocessor.
244
Finally, we interrogated the mRNA profiles of DGCR8-mutated schwannomas. The most 245 significantly differentially expressed mRNA in DGCR8-mutated as compared to wild type 246 schwannomas was KRAS (Fold Change 2.6; p = 3.03 -7 ; FDR = 1.27 -3 ), and NRAS was among 247 the top 10 (Fold Change 2.1; p = 2.42 -5 ; FDR = 5.89 -3 ) ( Figure 4A and Supplementary Table   248 10). In parallel, to interrogate pathways that are relevant in DGCR8-mutated schwannomas, we 
391
Schwannoma series: During the validation phase, we also interrogated DNA from 61 392 schwannomas (11 cases of which were previously sequenced using the custom DGCR8 393 Fluidigm Access Array) for evidence of other schwannoma genes using the HaloPlex HS assay 394 (Agilent) that incorporates molecular barcodes for high-sensitivity sequencing as a custom 395 design (43). Tumor DNA from the 11 schwanommas that were sequenced in parallel using the 396 Fluidigm Access Array were also sequenced using the Haloplex HS assay to cross-validate the 
399
MNGs and thyroid nodules: The germline DNA of 18 patients with familial MNGs or that 400 developed MNG plus another abnormality suggesting a DICER1-like phenotype was screened 401 for variants in DGCR8 by Sanger sequencing as described below. The E518K variant was also 402 screened in a total of 421 thyroid tumors by Sanger sequencing.
404
Targeted sequencing analysis methods
405
The Fluidigm-generated datasets were analyzed as previously described(44). In brief, the 406 HaloPlex HS targeted capture method is specifically designed to identify low allele frequency 407 variants through the attachment of a 10-nucleotide-long molecular barcode to the captured 408 sample DNA molecules. We followed an optimized protocol previously described in(43). The 
462
WES data were employed to interrogate the presence of LOH including copy number losses 463 and copy-neutral LOH.
465
Genome-wide copy number analysis
466
In parallel to the genome wide LOH analysis, OncoScan TM CNV SNP arrays were performed to 467 study somatic chromosomal aberrations in 4 MNG samples from II-2, III-1, III-2 and III-3 as well 468 as in the two unrelated PTC with the DGCR8-E518K mutation as previously described(49).
469
Array data has been included in the GEO repository (accession number GSE135374). 
618
Membranes were washed and incubated with donkey anti-rabbit IgG secondary antibody
619
(1:5000, GE Healthcare NA934) or sheep anti-mouse IgG secondary antibody (at 1:5000, GE
620
Healthcare, NA931). The revealing method used was Amersham ECL detection (Amersham
621
Biosciences). The experiments with pri-miR-30c-2 and pri-miR-223 were done in triplicates.
623
In vitro cleavage
624
Pri-miR-30c-2 and pri-miR-223 were prepared by in vitro transcription using the MAXIscript™ T7
625
Transcription Kit (ThermoFisher Scientific) in the presence of 5 ul of α-32 P UTP (Perkin Elmer).
626
Pri-miRNAs were purified and folded by incubation at 95ºC 3 min, 70ºC 3 min and cooled down 
